Loading...
Loading...
- AVEO Pharmaceuticals, Inc. AVEO shares jumped 85.5 percent to $1.35 after the company reported positive CHMP opinion for tivozanib for the treatment of advanced renal cell carcinoma.
- Synchronoss Technologies, Inc. SNCR surged 34.7 percent to $16.40. Siris Capital believes it is in a position to buy Synchronoss at $18 per share in cash.
- Root9B Holdings Inc RTNB shares rose 17.4 percent to $8.23.
- Cara Therapeutics Inc CARA shares climbed 17.1 percent to $23.27 after the company disclosed that it has received Breakthrough Therapy designation for IV CR845 for the treatment of chronic kidney disease-associated pruritus in hemodialysis patients.
- Finish Line Inc FINL shares gained 9.1 percent to $13.89. Finish Line reported in-line earnings for its first quarter, while sales missed estimates.
- Amyris Inc AMRS shares rose 8.8 percent to $3.58.
-
Barnes & Noble, Inc. BKS shares surged 8.6 percent to $7.60. Barnes & Noble reported a narrower-than-expected loss for its fourth quarter on Thursday.
- Aware, Inc. AWRE shares gained 9.5 percent to $5.20.
- AdvanSix Inc ASIX climbed 7.6 percent to $32.30. Cowen & Co. initiated coverage on AdvanSix with an Outperform rating.
- Forestar Group Inc. FOR rose 5.8 percent to $17.45. D.R. Horton, Inc. DHI raised its bid to acquire Forestar to $17.75 per share.
- Stemline Therapeutics Inc STML gained 5.6 percent to $8.98. Stemline Therapeutics presented SL-401 updated Stage 1 and 2 data from ongoing pivotal trial in BPDCN.
- Antares Pharma Inc ATRS jumped 5.3 percent to $3.17. H.C. Wainwright initiated coverage of Antares Pharma with a Buy rating.
- RH RH climbed 4.9 percent to $59.41. Deutsche Bank upgraded RH fom Hold to Buy.
- AK Steel Holding Corporation AKS shares gained 4.2 percent to $6.56. Deutsche Bank upgraded AK Steel from Hold to Buy.
- United States Steel Corporation X shares rose 4 percent to $21.91. Deutsche Bank upgraded United States Steel from Hold to Buy.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
